R Squared’s MaxCyte MXCT Stock Holding History

R Squared’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.3K	Buy	19,780 +7,720	+64%	+$7.69K	0.01%	482
2026 Q1	$8.47K	Buy	+12,060	New	+$11.3K	﹤0.01%	473
2025 Q3	–	Sell	-10,300	Closed	-$22.5K	–	652
2025 Q2	$22.5K	Buy	+10,300	New	+$24.9K	0.01%	439

Other funds holding MXCT

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $128M AUM

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

R Squared's MXCT Position: Q2 2026 in Review

R Squared increased its MaxCyte (MXCT) stake by 64% in Q2 2026, buying an estimated $7.69K and bringing the position to 19,780 shares worth $24.3K. The position accounts for 0.01% of the portfolio, ranked #482.

R Squared first reported a position in MXCT in Q2 2025 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

R Squared held 19,780 shares of MaxCyte worth $24.3K as of Q2 2026.
R Squared bought 7,720 MaxCyte shares in Q2 2026, an estimated $7.69K.
MaxCyte made up 0.01% of R Squared's portfolio in Q2 2026, its #482 holding.
R Squared first reported a position in MaxCyte in Q2 2025 and has held it in 3 quarters since.
123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.